Lantern PharmaLTRN
Market Cap: $43.8M
About: Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.
Employees: 21
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
1,088% more call options, than puts
Call options by funds: $309K | Put options by funds: $26K
83% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 6
15% more funds holding
Funds holding: 34 [Q1] → 39 (+5) [Q2]
1.62% more ownership
Funds ownership: 10.33% [Q1] → 11.95% (+1.62%) [Q2]
33% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 12
38% less capital invested
Capital invested by funds: $9.76M [Q1] → $6.01M (-$3.75M) [Q2]
Research analyst outlook
We haven’t received any recent analyst ratings for LTRN.